# SoftBank's Biotech Investments: 13 Startups in Its Portfolio (2026) > The 13 Biotech startups SoftBank has backed, by stage: $2.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/softbank-2-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 5 - [Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics) - [Pear Therapeutics](https://millionrounds.com/company/pear-therapeutics) - [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics) - [Vividion Therapeutics](https://millionrounds.com/company/vividion-therapeutics) - [Plexium](https://millionrounds.com/company/plexium) ## Series B 4 - [Repertoire Immune Medicines](https://millionrounds.com/company/repertoire-immune-medicines) - [Variant Bio](https://millionrounds.com/company/variant-bio) - [Hexagon Bio](https://millionrounds.com/company/hexagon-bio) - [Birdie](https://millionrounds.com/company/birdie) ## Stage not reported 4 - [Vir Biotechnology](https://millionrounds.com/company/vir-biotechnology) - [Alto Pharmacy](https://millionrounds.com/company/alto-pharmacy) - [LUMICKS](https://millionrounds.com/company/lumicks) - [Neumora Therapeutics](https://millionrounds.com/company/neumora-therapeutics) ## Segment by segment ### Series C and later 5 startups · $1.6B raised - [**Relay Therapeutics**](https://millionrounds.com/company/relay-therapeutics) Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. United States $932M - [**Pear Therapeutics**](https://millionrounds.com/company/pear-therapeutics) Pear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engage United States $239M - [**Dewpoint Therapeutics**](https://millionrounds.com/company/dewpoint-therapeutics) Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. United States $196M - [**Vividion Therapeutics**](https://millionrounds.com/company/vividion-therapeutics) We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with d United States $185M - [**Plexium**](https://millionrounds.com/company/plexium) Plexium is a biotechnology company based in San Diego, California, founded in 2018. United States $88M ### Series B 4 startups · $416M raised - [**Repertoire Immune Medicines**](https://millionrounds.com/company/repertoire-immune-medicines) Repertoire Immune Medicines is a clinical stage biotechnology company. - $189M - [**Variant Bio**](https://millionrounds.com/company/variant-bio) Variant Bio is a biotechnology company based in Seattle, founded in 2018. United States $105M - [**Hexagon Bio**](https://millionrounds.com/company/hexagon-bio) Hexagon Bio is a biopharmaceutical company based in Menlo Park, California, founded in 2016. United States $77M - [**Birdie**](https://millionrounds.com/company/birdie) Birdie is the CX intelligence platform that turns every customer signal into a real business decision, and the customer context l United Kingdom $45M ### Stage not reported 4 startups · $225M raised - [**Vir Biotechnology**](https://millionrounds.com/company/vir-biotechnology) Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions. United States $150M - [**Alto Pharmacy**](https://millionrounds.com/company/alto-pharmacy) Alto is a digital pharmacy that makes the prescription experience easier. United States $50M - [**LUMICKS**](https://millionrounds.com/company/lumicks) LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy. Netherlands $22M - [**Neumora Therapeutics**](https://millionrounds.com/company/neumora-therapeutics) Neumora Therapeutics operates as a clinical-stage biotechnology company. United States $2.6M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names SoftBank as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **SoftBank's AI portfolio** 47 startups · $91B](https://millionrounds.com/portfolio-maps/softbank-2-ai-portfolio)[Sector portfolio **SoftBank's Fintech portfolio** 14 startups · $2.0B](https://millionrounds.com/portfolio-maps/softbank-2-fintech-portfolio)[Co-investors **Who invests with SoftBank** 156 co-investors](https://millionrounds.com/portfolio-maps/softbank-2-co-investors)[Portfolio map **SoftBank portfolio map** 142 startups · $106B](https://millionrounds.com/portfolio-maps/softbank-2-portfolio-map)[Sector portfolio **EISMEA's Biotech portfolio** 73 startups · $656M](https://millionrounds.com/portfolio-maps/eismea-biotech-portfolio)[Sector portfolio **EISMEA's Healthtech portfolio** 30 startups · $97M](https://millionrounds.com/portfolio-maps/eismea-healthtech-portfolio) ## Raising from investors like SoftBank? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)